Sunday, 4 October 2026European Markets

SPBK1 HELGELAND And BANK OF IRELAND GP Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(VIANEWS) - SPBK1 HELGELAND (HELG.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Financial Services sector.

Financial Asset Price Forward Dividend Yield Return on Equity
SPBK1 HELGELAND (HELG.OL) kr131.00 8.02% 11.4%
BANK OF IRELAND GP (BIRG.IR) €8.22 2.59% 12.05%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. SPBK1 HELGELAND (HELG.OL)

8.02% Forward Dividend Yield and 11.4% Return On Equity

SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company is also involved in owning, managing, and letting commercial properties. It operates through branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.

Earnings Per Share

As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr16.

PE Ratio

SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 8.19. Meaning, the purchaser of the share is investing kr8.19 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.4%.

Volume

Today's last reported volume for SPBK1 HELGELAND is 5839 which is 53.73% above its average volume of 3798.

More news about SPBK1 HELGELAND.

2. BANK OF IRELAND GP (BIRG.IR)

2.59% Forward Dividend Yield and 12.05% Return On Equity

Bank of Ireland Group plc provides various banking and financial products and services. It provides current and savings accounts, and business deposits and accounts; personal, car, home improvement, graduate, motor finance, and student loans, as well as overdrafts; and business and farming loans, BREXIT loans, invoice finance, hire purchase, and leasing services. The company also offers international payments and credit cards; protection overview, mortgage protection, life cover, specified illness cover, income protection, protection for individuals, and protection for families; pensions and investments, foreign exchange, and treasury deposits and services; personal products; private banking services; and leveraged acquisition and property finance. In addition, it provides home, car, travel, and life insurance products. The company was founded in 1783 and is headquartered in Dublin, Ireland.

Earnings Per Share

As for profitability, BANK OF IRELAND GP has a trailing twelve months EPS of €1.27.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.05%.

More news about BANK OF IRELAND GP.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com